These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


283 related items for PubMed ID: 9572324

  • 1. Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
    Hawkey CJ.
    Am J Med; 1998 Mar 30; 104(3A):67S-74S; discussion 79S-80S. PubMed ID: 9572324
    [Abstract] [Full Text] [Related]

  • 2. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
    Yeomans ND.
    Am J Med; 1998 Mar 30; 104(3A):56S-61S; discussion 79S-80S. PubMed ID: 9572322
    [Abstract] [Full Text] [Related]

  • 3. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY.
    Am J Med; 2001 Jan 08; 110(1A):58S-61S. PubMed ID: 11166000
    [Abstract] [Full Text] [Related]

  • 4. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
    Hawkey CJ, Karrasch JA, Szczepañski L, Walker DG, Barkun A, Swannell AJ, Yeomans ND.
    N Engl J Med; 1998 Mar 12; 338(11):727-34. PubMed ID: 9494149
    [Abstract] [Full Text] [Related]

  • 5. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study.
    Ekström P, Carling L, Wetterhus S, Wingren PE, Anker-Hansen O, Lundegårdh G, Thorhallsson E, Unge P.
    Scand J Gastroenterol; 1996 Aug 12; 31(8):753-8. PubMed ID: 8858742
    [Abstract] [Full Text] [Related]

  • 6. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users.
    Graham DY.
    Helicobacter; 2002 Feb 12; 7(1):1-8. PubMed ID: 11886469
    [Abstract] [Full Text] [Related]

  • 7. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users.
    Cullen D, Bardhan KD, Eisner M, Kogut DG, Peacock RA, Thomson JM, Hawkey CJ.
    Aliment Pharmacol Ther; 1998 Feb 12; 12(2):135-40. PubMed ID: 9692687
    [Abstract] [Full Text] [Related]

  • 8. Prevention of the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: the role of proton pump inhibitors.
    Brown GJ, Yeomans ND.
    Drug Saf; 1999 Dec 12; 21(6):503-12. PubMed ID: 10612273
    [Abstract] [Full Text] [Related]

  • 9. Management of nonsteroidal anti-inflammatory drug-associated lesions: a cost-effectiveness perspective.
    Jönsson B, Wahlqvist P.
    Am J Med; 1998 Mar 30; 104(3A):81S-88S. PubMed ID: 9572326
    [Abstract] [Full Text] [Related]

  • 10. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Labenz J, Blum AL, Bolten WW, Dragosics B, Rösch W, Stolte M, Koelz HR.
    Gut; 2002 Sep 30; 51(3):329-35. PubMed ID: 12171952
    [Abstract] [Full Text] [Related]

  • 11. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
    Lad R, Armstrong D.
    Can J Gastroenterol; 1999 Mar 30; 13(2):135-42. PubMed ID: 10203432
    [Abstract] [Full Text] [Related]

  • 12. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD, Wilde MI.
    Drugs; 1998 Sep 30; 56(3):447-86. PubMed ID: 9777317
    [Abstract] [Full Text] [Related]

  • 13. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects.
    Lazzaroni M, Bianchi Porro G.
    Dig Liver Dis; 2001 Dec 30; 33 Suppl 2():S44-58. PubMed ID: 11827362
    [Abstract] [Full Text] [Related]

  • 14. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ, Agrawal NM.
    Dig Dis; 1995 Jan 30; 13 Suppl 1():48-61. PubMed ID: 7697902
    [Abstract] [Full Text] [Related]

  • 15. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
    Yeomans ND, Tulassay Z, Juhász L, Rácz I, Howard JM, van Rensburg CJ, Swannell AJ, Hawkey CJ.
    N Engl J Med; 1998 Mar 12; 338(11):719-26. PubMed ID: 9494148
    [Abstract] [Full Text] [Related]

  • 16. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 12; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 17. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ, Agrawal NM.
    J Physiol Pharmacol; 1995 Mar 12; 46(1):3-16. PubMed ID: 7599335
    [Abstract] [Full Text] [Related]

  • 18. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
    Hawkey CJ, Naesdal J, Wilson I, Långström G, Swannell AJ, Peacock RA, Yeomans ND.
    Gut; 2002 Sep 12; 51(3):336-43. PubMed ID: 12171953
    [Abstract] [Full Text] [Related]

  • 19. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
    Bianchi Porro G, Lazzaroni M, Petrillo M, Manzionna G, Montrone F, Caruso I.
    Ital J Gastroenterol Hepatol; 1998 Feb 12; 30(1):43-7. PubMed ID: 9615264
    [Abstract] [Full Text] [Related]

  • 20. Healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions, and relief of dyspeptic symptoms: a commentary on the new data.
    Talley NJ.
    Am J Med; 1998 Mar 30; 104(3A):62S-66S; discussion 79S-80S. PubMed ID: 9572323
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.